|
|
|
|
Direct Cost |
Indirect Cost |
|
1F30HL128034-01 |
Role of the SphK1/S1P Signaling Axis in the Pathogenesis of Pulmonary Arterial Hypertension |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NHLBI |
$48,120 |
|
$48,120 |
1F31AT008535-01A1 |
Metabolomic botanical standardization for pharmacokinetic interactions |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCCIH |
$42,084 |
|
$42,084 |
1F31CA192822-01 |
Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCI |
$43,120 |
|
$43,120 |
1F31HL127996-01 |
Beta-arrestin Signaling and Sarcomere Calcium-Response in Familial Dilated Cardiomyopathy |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NHLBI |
$37,965 |
|
$37,965 |
1F31MH108258-01 |
Neurodevelopmental Perspective on Inflammation, Loss, and Neurocognition |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIMH |
$43,120 |
|
$43,120 |
1F32AI115954-01 |
Functional analyses of a Listeria secretion chaperone essential for virulence |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIAID |
$54,194 |
|
$54,194 |
1F32DK105673-01 |
Correcting the beta-globin mutation in iPS cells for treatment of sickle cell disease. |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIDDK |
$52,406 |
|
$52,406 |
1K08DE024531-01A1 |
The Role of microRNA-21, 27 and 29 in Tooth Movement |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIDCR |
$129,145 |
$10,332 |
$139,477 |
1K23GM112014-01A1 |
Improving treatment personalization for pulmonary hypertension associated with diastolic heart failure |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIGMS |
$166,819 |
$10,146 |
$176,965 |
1K23HL125984-01A1 |
Genetics and Genomics of Sickle Cell Nephropathy. |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NHLBI |
$134,145 |
$10,732 |
$144,877 |
1K23MH105539-01A1 |
Parametric Rumination Induction as a Mood Endophenotype in Remitted Adolescents |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIMH |
$0 |
$0 |
|
1K23MH105553-01A1 |
Brain-Behavior Markers of Negative Affectivity, Comorbidity in Anxiety Disorders |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIMH |
$149,979 |
$11,878 |
$161,857 |
1P20CA202908-01 |
1/2 The GUIDE Cancer Research Training Project |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCI |
$140,251 |
$83,894 |
$224,145 |
1P50AA022538-01 |
Center for Alcohol Research in Epigenetics |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIAAA |
$1,024,061 |
$598,664 |
$1,622,725 |
1R01AI116441-01 |
EVALUATION OF A LYMPHATIC FILARIASIS VACCINE IN NON-HUMAN PRIMATES |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NIAID |
$492,529 |
$138,055 |
$630,584 |
1R01AT009169-01 |
Mechanism of Action for n-3 PUFA antidepressant properties |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCCIH |
$150,000 |
$89,738 |
$239,738 |
1R01CA178061-01A1 |
Statistical Qualification of the Impact of Missing Data in EMA Studies |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCI |
$207,631 |
$92,335 |
$299,966 |
1R01CA184681-01A1 |
Context and Subjective Experience Surrounding Dual Cigarette and E Cigarette Use |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCI |
$499,989 |
$299,035 |
$799,024 |
1R01CA188017-01A1 |
Partial Agonists at Estrogen Receptor alpha for Breast Cancer Therapy |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCI |
$310,853 |
$174,636 |
$485,489 |
1R01CA188427-01A1 |
Regulation of tyrosine kinase signaling through interaction with membrane lipids |
UNIVERSITY OF ILLINOIS AT CHICAGO |
NCI |
$273,900 |
$156,147 |
$430,047 |